Navigation Links
Aspirin and atherosclerosis
Date:9/22/2008

Aspirin has become one of the most widely used medications in the world, owing to its ability to reduce pain, fevers, inflammation, and blood clotting. In animal studies, aspirin has also been shown to prevent atherosclerosis, though none of its known mechanisms of action would seem to account for this. In a new study, though, researchers have uncovered the mechanism that may explain aspirin's ability to prevent arterial plaque buildup.

Using cell culture and mouse models, Sampath Parthasarathy and colleagues observed that aspirin specifically its active byproduct salicylate can greatly increase the expression of two proteins: paraoxonase 1 (PON1) and apolipoprotein A1 (ApoA1); in the mouse studies, low dose aspirin supplements could increase PON1 and ApoA1 levels by 7- and 12- fold, respectively.

Both of these proteins are beneficial components of the HDL complex, the "good cholesterol" that helps prevent atherosclerosis; ApoA1 removes bad cholesterol from the bloodstream while PON1 is an antioxidant that breaks down toxic lipid peroxides.

The researchers also noted that the heightened expression of PON1 was accompanied by an increase in a receptor called AHR (aryl hydrocarbon receptor); this was intriguing as a chemical known to attach to AHR is resveratrol, the "heart healthy" component of red wine.


'/>"/>

Contact: Nick Zagorski
nzagorski@asbmb.org
301-634-7366
American Society for Biochemistry and Molecular Biology
Source:Eurekalert

Page: 1

Related biology news :

1. Plants in forest emit aspirin chemical to deal with stress; discovery may help agriculture
2. Ultra-low-dose aspirin might decrease bleeding severity in portal hypertension
3. Failure to bridle inflammation spurs atherosclerosis
4. Lipoic acid could reduce atherosclerosis, weight gain
5. Nicotine may accelerate atherosclerosis, may be as dangerous as tar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... professional baseball pitchers with poor core stability are more likely ... because of injury than are pitchers who have good control ... the study, 347 pitchers were assessed for lumbopelvic control during ... they raised a leg to step up were up to ... cumulative, not consecutive during the season than were ...
(Date:9/2/2014)... issue of The FASEB Journal , ... the leading cause of blindness in adults, diabetic ... advance involves quantifying the early molecular changes caused ... Using new probes developed by scientists, they were ... diabetic retinopathy. , "My goal is to establish ...
(Date:9/2/2014)... September 2, 2014 Best-selling author Sam Kean stops ... the Megalodon, the 50-foot super shark that, despite what ... extinct. Learn all about it at http://youtu.be/KhFygIoW_MA . ... Tales of Madness, Love and the History of the ... getting the Reactions treatment in a 10-episode video series ...
Breaking Biology News(10 mins):In pro baseball pitchers, weak core linked to more missed days 2In pro baseball pitchers, weak core linked to more missed days 3Molecular probes permit doctors to detect diabetic retinopathy before vision fails 2
... pet rescue organizations are growing in number, working ... Although the majority of these organizations operate out ... winning high visibility for placing their pooches. , ... of the American Sociological Association (ASA) in Philadelphia, ...
... threatened by exotic species of the moon jellyfish being ... Using genetic data and computer simulations of ocean currents ... South Wales and the University of California, Davis, have ... naturally, according to a report in today's Proceedings of ...
... new study has found that the allergenicity of peanut ... process. Researchers from North Carolina A&T University report their ... American Society for Microbiology. , "Due to the wide ... snacks and even soups there is a need to ...
Cached Biology News:Virtual animal shelters ?How the Internet is transforming the experience of pet adoptions 2Ships bring alien jellyfish invaders to our shores 2
(Date:9/2/2014)... - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced ... three large odour control systems for waste water treatment plants ... are consistent with the market resurgence in North ... CEO. "After a difficult period of restraint in our core ... sales growth. Our lower cost structure, technology improvements and supply ...
(Date:9/2/2014)... September 2, 2014 Culot brings ... and lab management services  BioData, producer of ... pleased to announce the appointment of Louis Culot ... served as VP Marketing and Business Development at BioDiscovery ... and clinical applications. Previously, Culot worked for ...
(Date:9/1/2014)... September 01, 2014 The global ... million by 2019 from $1,070.7 million in 2014, ... to 2019. The global oligonucleotide synthesis market is ... applications, end users, and geography. The synthesized oligonucleotides ... rate in the oligonucleotide synthesis market during the ...
(Date:8/31/2014)... (PRWEB) September 01, 2014 Available ... lighting needs for research and cultivation of a ... by Valoya’s proprietary LEDs with proven patented and ... ensures uncompromised light uniformity in critical applications in ... white LEDs. , “Our customers have a large ...
Breaking Biology Technology:Louis Culot Appointed as BioData's CEO 29.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 29.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 39.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 49.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 5
... AMSTERDAM, November 11 Amsterdam Molecular,Therapeutics (Euronext: AMT), ... today that it has successfully treated Duchenne muscular dystrophy,(DMD) ... The proof of,concept studies were performed in collaboration with ... Sapienza, Italy) and demonstrated,effectiveness in the heart as well ...
... THE WOODLANDS, Texas, Nov. 10 Today, US ... , executive vice president and general counsel, will be ... http://www.newscom.com/cgi-bin/prnh/20091110/DA08765 ) , Watts has had a long ... worked with US Oncology providing legal services and consultation as ...
... , ST. LOUIS, Nov. 10 At the Board of ... dividend of $.145 per share, an 11.5% increase over the ... 2009 to shareholders of record on December 1, 2009. , ... Life Science and High Technology company. Our chemical and biochemical ...
Cached Biology Technology:AMT Successful in Preclinical Treatment of DMD 2AMT Successful in Preclinical Treatment of DMD 3US Oncology Announces Retirement of General Counsel Phil Watts 2
TRIS-EDTA based buffer prepared from RNase-free water suitable for storage and dilution of siRNA, pH 8, store at 4 C ...
Request Info...
...
Request Info...
Biology Products: